Interestingly, different cytokine profiles have been identified among ALS subgroups, since MCP-1 was higher in patients with a clinically probable EL Escorial diagnostic category, and sICAM was higher in patients with a UMNp clinical phenotype, suggesting their potential relationship with disease progression or the kind of MN involvement. The gene discussed is CCL2; the disease is amyotrophic lateral sclerosis.